TLDRocket
Sign in

Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

+ Follow this topic

Tuesday, 8 September 2026

AlphaGenome Atlas

Product Hunt 1 month ago 37 ● 6 sources

AlphaGenome Atlas launches today as a Google DeepMind AI-powered map of how human DNA mutations may affect biology. It includes precomputed predictions for 9 billion possible single-letter DNA changes in a 1-petabyte dataset. Researchers can now explore and prioritize variants through a free web interface, with API access for deeper work.

Early Data Indicates an AI-Generated Drug Could Slow Aging

The New York Times 1 month ago 38 ● 3 sources

Rentosertib, an AI-assisted drug candidate, showed early evidence that it may slow aging beyond treating chronic lung disease. It reduced biological-age markers across six aging clocks. The results mean the drug’s potential is expanding to aging, though it is still years away from regulatory approval.

Insilico’s AI-designed drug made patients look biologically younger on six aging clocks

Nature Publishing Group US 1 month ago 8 ● 3 sources

Insilico’s AI-designed TNIK inhibitor rentosertib (INS018_055) was evaluated in a phase 2a IPF trial using serum proteomics analyzed by six proteomic aging clocks. At 12 weeks, 21 of 54 treatment-vs-placebo clock comparisons were statistically significant, with most occurring at week 4. All six clocks showed reduced predicted biological age in treated groups versus minimal change in placebo, shifting trial readouts toward measurable aging-rate deceleration alongside disease effects.

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.